FDA daily for Tuesday, September 1, 2026
30 FDA records across 3 sections. 2 touch MedGrid's categories and are listed first.
FDA did not answer for Label changes while this issue was written; those sections will fill in on a later visit.
Drug shortagesCovers FDA's Mon, Aug 31 (yesterday)2 touch MedGrid11
- Medroxyprogesterone Acetate TabletTouches MedGrid categories
PROVERA, Tablet, 10 mg (NDC 0009-0051-01) — Pfizer Inc.
- Medroxyprogesterone Acetate TabletTouches MedGrid categories
PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01) — Pfizer Inc.
- Metoprolol Succinate Tablet, Extended Release
Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11) — Teva Pharmaceuticals USA, Inc.
- Metoprolol Succinate Tablet, Extended Release
Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11) — Teva Pharmaceuticals USA, Inc.
- Metoprolol Succinate Tablet, Extended Release
Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96) — Teva Pharmaceuticals USA, Inc.
- Metoprolol Succinate Tablet, Extended Release
Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11) — Teva Pharmaceuticals USA, Inc.
- Metoprolol Succinate Tablet, Extended Release
Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11) — Teva Pharmaceuticals USA, Inc.
- Metoprolol Succinate Tablet, Extended Release
Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96) — Teva Pharmaceuticals USA, Inc.
- Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution
Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC 65219-258-10) — Fresenius Kabi USA, LLC
- Palovarotene Capsule
SOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1) — Ipsen Biopharmaceuticals, Inc.
- Metoprolol Succinate Tablet, Extended Release
Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96) — Teva Pharmaceuticals USA, Inc.
Drug approvalsCovers FDA's Tue, Aug 25 (a week ago)9
- FLUTICASONE PROPIONATE
FLUTICASONE PROPIONATE — AUROBINDO PHARMA LTD
- ZIIHERA
ZANIDATAMAB-HRII — JAZZ PHARMS
- TADALAFIL
TADALAFIL — SUN PHARM
- METOPROLOL SUCCINATE
METOPROLOL SUCCINATE — HETERO LABS LTD III
- TIVICAY
DOLUTEGRAVIR SODIUM — VIIV HLTHCARE
- TIVICAY PD
DOLUTEGRAVIR SODIUM — VIIV HLTHCARE
- GABAPENTIN
GABAPENTIN — RUBICON RESEARCH
- TEVIMBRA
TISLELIZUMAB-JSGR — BEIGENE
- ISOPROTERENOL HYDROCHLORIDE
ISOPROTERENOL HYDROCHLORIDE — EUGIA PHARMA
Device clearancesCovers FDA's Tue, Aug 18 (two weeks ago)10
- BluEX Cervical Expandable Cage System
L&K BIOMED Co., Ltd.
- Lancing device
Tianjin Huahong Technology Co., Ltd.
- TearCare System
Sight Sciences, Inc.
- Tympendi (810)
Grace Medical, Inc.
- NON-STERILE POWDER FREE NITRILE PATIENT EXAMINATION GLOVES, WITH LICORICE ROOT EXTRACT AND UREA, TESTED FOR USE WITH CH…
Kossan International Sdn Bhd
- TeKBrace Solo Soft Tissue Reinforcement Device
Theramicro
- LUOFUCON® Wound Matrix
Huizhou Foryou Medical Devices Co., Ltd.
- Lower Limb AI (LLAI)
AI Planning Logic, Inc.
- p17 XR Microcatheter
Wallaby Medical
- HERizon RD5 Resecting Device (5FR1PK);HERizon RD5 Resecting Device - 5 pack (5FR5PK)
Axora Medical, Inc.
How the FDA Daily Is WrittenSources, dates and what gets flagged
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug recalls, device recalls and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Items that touch the categories MedGrid works in, such as GLP-1s, hormones, injectables, peptides, compounded products and aesthetic devices, are marked and listed first.
Subscribe with any feed reader, or point an email tool at theRSS feed. For the rules behind the headlines, see Regulations Research.
Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.